APOE orchestrated ''molecular signatures'' in aging brain and AD - the contribution of APOE2

APOE 在衰老大脑和 AD 中精心策划了“分子特征”——APOE2 的贡献

基本信息

项目摘要

APOE (Apolipoprotein E) is part of APOE/APOC gene cluster on chromosome 19 and codes for 3 protein isoforms – APOE2, APOE3 and APOE4. APOE transports cholesterol and phospholipids in the periphery and brain. APOE isoforms differ in their lipid and receptor binding capacity and their role is associated with clearance of LDL, VLDL and chylomicrons. The inheritance of APOE4 allele increases and APOE2 decreases the risk for late onset AD (LOAD), but the mechanism is poorly understood. While APOE is involved in critical cellular functions such as oxidative processes, inflammation, glial cell and neuronal homeostasis, none of those can be dissociated from isoform specific binding, transport and delivery of cholesterol and phospholipids to different cell types. Recent reports suggest there might be a differential APOE-isoform specific effect on microglia mediated phagocytosis and function of immune receptors expressed in brain. Our preliminary data demonstrate APOE isoforms influence expression of immune receptors Dectin-1/Clec7a, Siglec1, Siglech, Oscar - involved in inflammatory response and phagocytosis. A strong support to an interconnected role for APOE and immune receptor mediated phagocytosis are our results of Multi-Dimensional Mass Spectrometry Shotgun Lipidomics of brain samples from AD patients, where we find significant differences in phospholipid molecular speciation in major phospholipid classes. We hypothesize the APOE isoform-specific effects on phagocytosis are driven by the different phospholipid composition of APOE lipid particles and/or by the differential effect of APOE isoforms on microglial transcriptome. We are proposing 3 Specific Aims to test the hypothesis: Aim 1. Establish isoform- dependent effect of APOEε2 allele on brain parenchymal and mitochondrial lipidome and transcriptome in AD patients and non-demented controls. The goal is to integrate lipid and transcriptional profiles and to reveal APOE allele controlled phenotypes and lipid molecular species for additional functional assays in SA3. Aim 2. Determine isoform- and age-dependent effect of APOE genotype on brain lipidome and transcriptome in mice expressing human APOE2, APOE3 or APOE4 isoforms. We will determine phospholipid content of native APOE in Astrocyte Conditioned media, lipid particles in brain interstitial fluid (ISF) and differences in brain parenchyma and mitochondrial lipidomes between mice expressing APOE2, APOE3 or APOE4 isoforms at 2 different ages. Aim 3. To test the effect of APOE-containing nanoparticles on Aβ phagocytosis in vitro and in vivo. The goals are to apply the knowledge about differences in lipid compositions of AD and mouse brains and to test the effect of phospholipid molecular species on microglia mediated Aβ phagocytosis and clearance of Aβ oligomeric species in in vitro and in vivo experimental systems.

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Genome-wide alteration of histone methylation profiles associated with cognitive changes in response to developmental arsenic exposure in mice.
  • DOI:
    10.1016/j.toxrep.2022.03.008
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fitz NF;Barchowsky A;Koldamova R;Lefterov I
  • 通讯作者:
    Lefterov I
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RADOSVETA KOLDAMOVA其他文献

RADOSVETA KOLDAMOVA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RADOSVETA KOLDAMOVA', 18)}}的其他基金

The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesis
Tau 和 ncRNA 之间的相互作用 — 早期 AD 发病机制的基因组和表观基因组线索
  • 批准号:
    10447273
  • 财政年份:
    2022
  • 资助金额:
    $ 44.06万
  • 项目类别:
The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesis
Tau 和 ncRNA 之间的相互作用 — 早期 AD 发病机制的基因组和表观基因组线索
  • 批准号:
    10634661
  • 财政年份:
    2022
  • 资助金额:
    $ 44.06万
  • 项目类别:
ncRNAs in plasma EVs of AD patients and their discriminatory power as biomarkers
AD 患者血浆 EV 中的 ncRNA 及其作为生物标志物的区分能力
  • 批准号:
    10532000
  • 财政年份:
    2022
  • 资助金额:
    $ 44.06万
  • 项目类别:
APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2
APOE 在衰老大脑和 AD 中精心设计的分子特征——APOE2 的贡献
  • 批准号:
    10450775
  • 财政年份:
    2018
  • 资助金额:
    $ 44.06万
  • 项目类别:
APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2
APOE 在衰老大脑和 AD 中精心设计的分子特征——APOE2 的贡献
  • 批准号:
    10170188
  • 财政年份:
    2018
  • 资助金额:
    $ 44.06万
  • 项目类别:
Epigenetic and phenotypic effects of arsenic: impacts on cognition and AD
砷的表观遗传和表型效应:对认知和 AD 的影响
  • 批准号:
    8755745
  • 财政年份:
    2014
  • 资助金额:
    $ 44.06万
  • 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
  • 批准号:
    8103681
  • 财政年份:
    2011
  • 资助金额:
    $ 44.06万
  • 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
  • 批准号:
    8484324
  • 财政年份:
    2011
  • 资助金额:
    $ 44.06万
  • 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
  • 批准号:
    8277207
  • 财政年份:
    2011
  • 资助金额:
    $ 44.06万
  • 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
  • 批准号:
    8665344
  • 财政年份:
    2011
  • 资助金额:
    $ 44.06万
  • 项目类别:

相似海外基金

Mechanistic dissection of allosteric modulation and nonproteolytic chaperone activity of human insulin-degrading enzyme
人胰岛素降解酶变构调节和非蛋白水解伴侣活性的机制剖析
  • 批准号:
    10667987
  • 财政年份:
    2023
  • 资助金额:
    $ 44.06万
  • 项目类别:
Astrocytic exocytosis of ATP in amyloid pathology and Alzheimer's disease
淀粉样蛋白病理学和阿尔茨海默病中 ATP 的星形细胞胞吐作用
  • 批准号:
    10722422
  • 财政年份:
    2023
  • 资助金额:
    $ 44.06万
  • 项目类别:
Cerebrovascular mitochondria as mediators of neuroinflammation in Alzheimer's Disease
脑血管线粒体作为阿尔茨海默病神经炎症的介质
  • 批准号:
    10723580
  • 财政年份:
    2023
  • 资助金额:
    $ 44.06万
  • 项目类别:
Bisphenol-Induced Blood-Brain Barrier Dysfunction in Alzheimer’s Disease
双酚引起的阿尔茨海默氏病血脑屏障功能障碍
  • 批准号:
    10713025
  • 财政年份:
    2023
  • 资助金额:
    $ 44.06万
  • 项目类别:
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
研究脑脊液产生和循环在衰老和阿尔茨海默病中的作用
  • 批准号:
    10717111
  • 财政年份:
    2023
  • 资助金额:
    $ 44.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了